Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

51.2K
Overview
51.2K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

485
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
485
International Nursing Organizations II01:28

International Nursing Organizations II

1.3K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Infection01:20

Infection

11.8K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
11.8K
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

928
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
928

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Wassilak et al. Impediments to Progress Toward Polio Eradication During 2014-2024: Effectively Addressing the Current Challenges. <i>Vaccines</i> 2025, <i>13</i>, 1060.

Vaccines·2025
Same author

Update on Vaccine-Derived Poliovirus Outbreaks - Worldwide, January 2023-June 2024.

MMWR. Morbidity and mortality weekly report·2024
Same author

Increasing Population Immunity Prior to Globally-Coordinated Cessation of Bivalent Oral Poliovirus Vaccine (bOPV).

Pathogens (Basel, Switzerland)·2024
Same author

Assessing the mucosal intestinal and systemic humoral immunity of sequential schedules of inactivated poliovirus vaccine and bivalent oral poliovirus vaccine for essential immunization in Bangladesh: An open-label, randomized controlled trial.

Vaccine·2024
Same author

Progress Toward Poliomyelitis Eradication - Worldwide, January 2022-December 2023.

MMWR. Morbidity and mortality weekly report·2024
Same author

Poliovirus type 1 systemic humoral and intestinal mucosal immunity induced by monovalent oral poliovirus vaccine, fractional inactivated poliovirus vaccine, and bivalent oral poliovirus vaccine: A randomized controlled trial.

Vaccine·2023
Same journal

Correction: Fukushima et al. Long-Term Immunogenicity of Rabies Pre-Exposure Prophylaxis in Japanese Adult Travelers: Comparison of Dosing Regimens. <i>Vaccines</i> 2025, <i>13</i>, 1169.

Vaccines·2026
Same journal

Access to Vaccines Among Asylum Seekers, Refugees, and Undocumented Migrants Across the Migratory Cycle in the European Union, European Economic Area, Switzerland and the United Kingdom: A Scoping Review.

Vaccines·2026
Same journal

Advances in Detection Methods for Human Respiratory Syncytial Virus Neutralizing Antibodies.

Vaccines·2026
Same journal

Insights from 25 Years of Measles and Measles-Rubella Vaccination Campaigns in the WHO African Region (2001-2025).

Vaccines·2026
Same journal

Post-Marketing Safety Surveillance of Influenza Vaccines in Anhui Province, China, 2016-2025.

Vaccines·2026
Same journal

Characteristics of Hypotonic-Hyporesponsive Episodes (HHEs) Following Childhood Vaccination: A 13-Year Analysis of Spontaneous Reports to the Dutch Pharmacovigilance Centre Lareb.

Vaccines·2026
See all related articles

Related Experiment Video

Updated: Jan 13, 2026

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.9K

Impediments to Progress Toward Polio Eradication During 2014-2024: Effectively Addressing the Current Challenges.

Steven G F Wassilak1, Abdinoor Mohamed2, John Paul Bigouette2

  • 1Independent Researcher, Atlanta, GA 30307, USA.

Vaccines
|October 28, 2025
PubMed
Summary
This summary is machine-generated.

Global polio eradication efforts face significant hurdles, including decreased funding and political will, threatening progress. Urgent action is needed to overcome challenges and achieve a polio-free world.

Keywords:
Global Polio Eradication Initiativeimmunizationoutbreak responsepoliomyelitissecurity challengesvaccine hesitancyvaccine resistancevaccine-derived polioviruswild poliovirus

More Related Videos

Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

9.2K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.5K

Related Experiment Videos

Last Updated: Jan 13, 2026

Particle Agglutination Method for Poliovirus Identification
07:06

Particle Agglutination Method for Poliovirus Identification

Published on: April 20, 2011

15.9K
Whole Body Vibration Methods with Survivors of Polio
04:16

Whole Body Vibration Methods with Survivors of Polio

Published on: October 17, 2018

9.2K
Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

1.5K

Area of Science:

  • Public Health
  • Epidemiology
  • Infectious Disease Control

Background:

  • The Global Polio Eradication Initiative (GPEI) aimed for eradication by 2000, but challenges persist.
  • Wild poliovirus remains endemic in Afghanistan and Pakistan, with ongoing vaccine-derived poliovirus type 2 outbreaks.

Purpose of the Study:

  • To detail impediments to polio eradication progress since 2014.
  • To review challenges the GPEI must mitigate for successful global polio eradication.

Main Methods:

  • Review of impediments to polio eradication progress.
  • Analysis of challenges faced by the GPEI.

Main Results:

  • Persistent wild poliovirus transmission in Afghanistan and Pakistan.
  • Challenges include loss of urgency, declining immunization coverage, and reduced outbreak response quality.
  • Security issues and decreased GPEI funding pose acute threats.

Conclusions:

  • Eradication is achievable with urgent and effective mitigation of identified challenges.
  • Strengthening political will, routine immunization, and outbreak responses is crucial.
  • Addressing funding shortfalls is paramount to prevent reversal of progress.